In particular, one study found that TAMs in IBC tumors express high levels of CCL18, a chemokine known to promote angiogenesis, which was associated with lymph node involvement and poor survival outcomes in IBC patients [29]. This evidence concerns the gene CCL18 and inflammatory breast carcinoma.